Author:
Angori Silvia,Banaei-Esfahani Amir,Mühlbauer Katharina,Bolck Hella A.,Kahraman Abdullah,Karakulak Tülay,Poyet Cédric,Feodoroff Michaela,Potdar Swapnil,Kallioniemi Olli,Pietiäinen Vilja,Schraml Peter,Moch Holger
Reference30 articles.
1. Comprehensive molecular characterization of papillary renal-cell carcinoma;The Cancer Genome Atlas Research Network;N Engl J Med,2016
2. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours;Moch;Eur Urol,2022
3. ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma;Powles;Ann Oncol,2021
4. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial;Pal;Lancet,2021
5. Comprehensive molecular characterization of clear cell renal cell carcinoma;The Cancer Genome Atlas Research Network;Nature,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献